Artificial Intelligence Platform for Precision Health
Artificial Intelligence Platform for Precision Health
LizAI innovates a cutting-edge AI platform that provides
life-changing solutions to millions of patients
LizAI Innovates A Cutting-Edge AI Platform That Provides Life-Changing Solutions To Millions Of Patients
About Us
LizAI Was Invented For Precision Health With An Ultimate Mission:
Providing Life-Changing Solutions To Patients
LizAI combines A diverse team of innovators, with solid expertise in sciences and technologies of precision health, including AI, big data, privacy-preserving, cloud APIs integration, pharmaceuticals, and clinical research.
Our technology disrupts the current AI models for healthcare by a superior innovative AI platform in its accuracy, speed, extendability, scalability, and security.
LizAI Platform
Integration of Cutting-Edge Sciences and Technologies
We share the market value of
LizAI’s Services
Our goal is to provide services to insurance companies, hospitals, pharmaceutical companies, and directly to users.
The significant burdens posed by Obese Diabetes (type II)
LizAI first-Line Product
Provides solutions to the challenges in treating Obese Diabetes (type II), in which area LizAI Inc. is the pioneer.
40%
US population
Lives with a high risk of Obese Diabetes, posing a significant burden on the healthcare system. The total yearly cost for these patients is $327B in the US.
There are at least 60 approved medicines. Moreover, obese diabetes itself is multifactorial and complex, which in many cases leads to other health complications (e.g., cardiac diseases, stroke, liver and kidney diseases, cancers, etc.) and requires combined drugs treatment. This is thus significantly challenging for doctors to evaluate the patients’ condition and effectively provide multiple drugs prescription.
Additionally, according to clinical reports, many of the prescribed drugs do not work as expected and need to be re-defined for each patient’s needs. The drug-to-drug interaction has not been systematically recorded and deeply studied, posing high risks of disease complications. Precision treatment is thus urgently needed.